iQ Sense: 24/7 Animal Health Monitoring Through Real-Time Biochemical Insight

Opportunity for

• Angel, VC or Family office investors with an interest in animal health intelligence technology.
• Veterinary pharmaceutical companies, veterinary groups and corporate practices, animal nutrition companies, animal health insurance providers, producer groups and livestock industry bodies, and research organisations and universities supporting animal health validation and field trials.

Opportunity description

Industry challenge: 

Across livestock and companion animals, most disease processes begin well before observable clinical signs appear. However, current monitoring and diagnostic approaches typically identify disease only after productivity declines, welfare is compromised, or intervention costs increase.

In agricultural systems, delayed detection contributes to reduced productivity and fertility, increased treatment and labour costs, higher antimicrobial use, and greater biosecurity and zoonotic disease risk.

Globally, livestock disease losses exceed $65B annually, with a significant proportion occurring during high-risk periods such as the dairy transition phase. Earlier detection represents a major opportunity to improve animal health outcomes, sustainability, and system resilience.

Current opportunity:

iQ Sense is developing a next-generation animal health intelligence platform enabling 24/7, real-time biochemical monitoring in animals, allowing disease to be detected before clinical signs emerge.

The company is currently raising pre-seed funding to complete prototype development, validate the platform in live animals, and launch partner-led pilot trials. This phase is designed to support an 18-month runway focused on technical validation, pilot deployment, and commercial readiness.

iQ Sense is seeking partners to support in-vivo validation and pilot trials, disease- and biomarker-specific co-development, integration into existing animal health and production systems, and early commercial deployment pathways.

Opportunity background:

iQ Sense has secured multiple non-dilutive grants, including Critical Technologies Programme and MOD funding, totalling over $500K AUD, demonstrating strong technical validation and delivery capability.

The company has established collaborations with the University of Queensland and the University of Nottingham, with additional international research and industry partners under evaluation. These collaborations support ongoing biosensor validation, translational research, and preparation for real-world deployment across companion animal and livestock systems.